Ying Fei-Wei

Title: Innovations of Ying Fei-Wei

Introduction

Ying Fei-Wei is a notable inventor based in Darnestown, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. With a total of 2 patents to his name, his work has the potential to impact various medical treatments.

Latest Patents

Ying Fei-Wei's latest patents include the invention of transforming growth factor alpha HI and transforming growth factor alpha HII polypeptides. These inventions disclose polypeptides and polynucleotides encoding such polypeptides. The procedures for producing these polypeptides utilize recombinant techniques. The therapeutic uses of these polypeptides encompass stimulating wound healing, treating neurological disorders, addressing ocular disorders, and managing kidney and liver disorders. Additionally, they play a role in stimulating embryogenesis and angiogenesis. The patents also disclose antagonists against these polypeptides, which can be used therapeutically to treat neoplasia. Furthermore, diagnostic assays for detecting altered levels of the polypeptides and mutations in the nucleic acid sequences encoding them are also included.

Career Highlights

Ying Fei-Wei is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research in genetic sciences. His work has contributed to the understanding and development of innovative treatments in the medical field.

Collaborations

Some of his notable coworkers include Paul S Meissner and Rebecca A Fuldner. Their collaborative efforts have further enhanced the research and development initiatives within their organization.

Conclusion

Ying Fei-Wei's contributions to biotechnology through his patents and work at Human Genome Sciences, Inc. highlight his role as an influential inventor in the field. His innovations have the potential to lead to significant advancements in medical therapies.